ODAC Recommends TICE BCG Approval For Recurrent Bladder Cancer Prevention
In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger
FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:
US Appeals Court Dismisses Fisher’s Privacy Act Suit Supporting Femara
Breast Cancer: Working Group Sets Broad Agenda For Genetic Research
Trending Stories
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
Susan Collins: Trump’s 40% cut is “so disturbing” - In The Headlines: Increasing incidence of early-onset cancer is “a paradigm shift oncology isn’t quite prepared for”
- The Directors: Candace Johnson and Jonathan Friedberg on living through uncertainty at NCI, payment woes
Directors of two neighboring cancer centers in Upstate New York will face challenges, but “we’ll get through it” - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Insights from ASCO 2025: Real-world evidence drives clinical decision-making